Work

A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Treatment-Naïve Patients with Higher-Risk Myelodysplastic Syndrome

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-124437

Authors: Andrew H. Wei, Jacqueline S Garcia, Uma Borate, Chun Yew Fong, Maria R. Baer, Florian Nolte, Pierre Peterlin, Joseph G. Jurcic, Guillermo Garcia-Manero, Wan-Jen Hong, Uwe Platzbecker, Olatoyosi Odenike, Martin Dunbar, Ying Zhou, Jason Harb, Poonam Tanwani, Johannes E. Wolff, Meagan Jacoby

Institutions: The Alfred Hospital, Monash University, Dana-Farber Cancer Institute, Oregon Health & Science University, OHSU Knight Cancer Institute, Olivia Newton-John Cancer Research Institute, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Stiftung Charité, Charité – Universitätsmedizin Berlin, Centre Hospitalier Universitaire de Nantes, Columbia University Irving Medical Center, The University of Texas MD Anderson Cancer Center, Genentech, University Hospital Leipzig, University of Chicago, University of Chicago Medicine Comprehensive Cancer Center, AbbVie (United States), Barnes-Jewish Hospital

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2990177100

Cites:

Cited by: 46

Related to: 10